Skip to content

Ultrafast diagnosis of epilepsy: a randomised controlled trial of AI-assisted interpretation of ambulatory EEG recordings versus routine care.

Ultrafast diagnosis of epilepsy: a randomised controlled trial of AI-assisted interpretation of ambulatory EEG recordings versus routine care. - Epilepsy assessment by AI supported EEG

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56882
Enrollment
Unknown
Registered
2024-04-09
Start date
2024-10-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy Epilepsy

Interventions

Patients are randomized into two treatment arms: the standard care arm and the ultra-fast AI arm. In the ultra-fast AI arm, an ambulant EEG recording is performed and analyzed by an artificial intel

Sponsors

Medisch Spectrum Twente (MST)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - The participant must be an adult (>=18 years). - The participant is referred for a routine EEG with the differential diagnosis of epilepsy.

Exclusion criteria

Exclusion criteria: - Patients with cognitive impairments that limits patients* understanding of the research purpose and to give informed consent. - Patients who previously have been diagnosed with epilepsy.

Design outcomes

Primary

MeasureTime frame
The main study parameter is the time-to-diagnosis, defined as the time (in weeks) from initial referral to final diagnosis of epilepsy.

Secondary

MeasureTime frame
- Total cost of each study arm. - Time spend by medical professionals reviewing the EEGs. - Sensitivity, specificity and F1 score of routine EEG and ambulatory EEG with AI. - Patient satisfaction score measured by the patient satisfaction questionnaire. - Time patients invested in the diagnostic process of both study arms.

Countries

Netherlands

Contacts

Public ContactE.C. Klaver

Medisch Spectrum Twente (MST)

Neurologie@mst.nl0534872850

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026